Today: 29 June 2026
Amazon stock slips before the bell as Trump raises global tariff to 15%
23 February 2026
1 min read

Amazon stock slips before the bell as Trump raises global tariff to 15%

New York, February 23, 2026, 06:54 EST — Premarket

Amazon.com (AMZN.O) slipped 0.7% to $208.54 in premarket deals on Monday, with the latest tariff news prompting traders to hold back. The stock had closed out Friday with a 2.6% gain, finishing at $210.11.

This hits Amazon from both sides—shoppers on one, inbound goods on the other. Tariffs end up raising supply chain costs, and if those stick around, the real question becomes how much sellers and retailers can nudge prices higher before shoppers start pulling back.

Amazon carries serious weight on the tape. As a top name in consumer discretionary, it often steers U.S. equity indexes, especially when risk sentiment shifts.

Futures on major U.S. stock indexes slipped after President Donald Trump rolled out a fresh 15% tariff, reigniting the uncertainty that had receded following Friday’s Supreme Court ruling. “It’s really hard … to know how do you plan,” said Arthur Laffer Jr., president at Laffer Tengler Investments, citing unstable supplier and supply chain calculations. Reuters

Trump announced over the weekend that he plans to hike the temporary blanket tariff to 15% from 10%—the ceiling allowed under Section 122, a seldom-invoked law. That statute lets tariffs run for 150 days, after which Congress must sign off to keep them in place. “His rapid-fire change underscored the uncertainty,” said Wendy Cutler, a former senior U.S. trade official now at the Asia Society. Reuters

The core issue for Amazon isn’t so much quarterly performance, but the mechanics at play: Do sweeping import tariffs tighten the screws on marketplace sellers, bump up costs for shoppers, or put a dent in demand if wallets get pinched? Its retail mix covers basics and discretionary buys alike, so not all price points react the same way.

But the picture isn’t one-sided. New legal hurdles, wider exemptions, or signs policymakers might soften their stance could mean traders dismiss Monday’s drop as little more than background noise—not a true reset.

The sharper risk? Sudden swings in tariff policy, whipsawing companies into scrambling—repricing goods, rerouting shipments, sometimes putting orders on ice. That typically hits earnings guidance before it ever makes headline news.

Next up for traders: an early Tuesday deadline. U.S. Customs and Border Protection plans to stop collecting tariffs imposed under the International Emergency Economic Powers Act at 12:01 a.m. EST, flagging further guidance is on its way. Any fresh details could swiftly reshape market expectations for both import costs and consumer prices.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • ASX Penny Stocks: Alligator Energy, Hearts and Minds, Hansen Technologies in Focus
    June 29, 2026, 3:56 PM EDT. Penny stocks on the ASX are grabbing attention as volatility continues. Alligator Energy (ASX:AGE) is still pre-revenue, valued at A$230.73 million, and betting on uranium exploration. The company is running deeper losses but says its cash should last 2.7 years, and analysts see a possible 62.8% jump in shares. Hearts and Minds Investments (ASX:HM1) has a market cap of A$670.92 million. The investment firm's profits are down 84.9%, and its 6.48% dividend yield has investors wondering about longevity. Hansen Technologies sits at a A$904.29 million market cap, pulling in revenue from its Energy & Utilities business. Together, the names show the range of plays and issues in the ASX penny stock scene.
Johnson & Johnson stock falls on DePuy sale talk — what to watch next for JNJ shares
Previous Story

Johnson & Johnson stock falls on DePuy sale talk — what to watch next for JNJ shares

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop